High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis

[1]  G. Valentini,et al.  NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity , 2019, Arthritis Research & Therapy.

[2]  K. Soylu,et al.  Microvascular abnormalities in asymptomatic chronic smokers: A videocapillaroscopic study. , 2019, Microvascular research.

[3]  W. Gyselaers,et al.  Capillaroscopy in pregnancy , 2017, Expert review of medical devices.

[4]  G. Maldonado,et al.  Nailfold capillaroscopy in diabetes mellitus. , 2017, Microvascular research.

[5]  G. Valentini,et al.  The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score , 2017, Arthritis Research & Therapy.

[6]  M. Baron,et al.  The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index , 2016, Annals of the rheumatic diseases.

[7]  D. Furst,et al.  Update of EULAR recommendations for the treatment of systemic sclerosis , 2015, Annals of the rheumatic diseases.

[8]  M. Doherty,et al.  Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies , 2015, BMJ Open.

[9]  C. Vitali,et al.  Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis , 2014, Arthritis Research & Therapy.

[10]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[11]  J. Pope,et al.  Meta‐Analysis of Healing and Prevention of Digital Ulcers in Systemic Sclerosis , 2013, Arthritis care & research.

[12]  F. Trautinger,et al.  Capillaroscopy , 2013, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[13]  Maurizio Cutolo,et al.  How to perform and interpret capillaroscopy. , 2013, Best practice & research. Clinical rheumatology.

[14]  R. D'amico,et al.  Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. , 2009, Arthritis and rheumatism.

[15]  C. Denton,et al.  Digital ulcers: overt vascular disease in systemic sclerosis. , 2006, Rheumatology.

[16]  B. Kahaleh.  The microvascular endothelium in scleroderma. , 2008, Rheumatology.

[17]  P. Boracchi,et al.  Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder: PRINCE (prognostic index for nailfold capillaroscopic examination). , 2008, Arthritis and rheumatism.

[18]  M. Cutolo,et al.  Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients , 2007, Annals of the rheumatic diseases.

[19]  U. Müller-Ladner,et al.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database , 2007, Annals of the rheumatic diseases.

[20]  E. Bouskela,et al.  Nailfold videocapillaroscopy in primary antiphospholipid syndrome (PAPS). , 2004, Rheumatology.

[21]  F. Ingegnoli,et al.  Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. , 2004, Arthritis and rheumatism.

[22]  A. Silman,et al.  European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria , 2003, Annals of the rheumatic diseases.

[23]  S. Bombardieri,et al.  Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.

[24]  A. Silman,et al.  European multicentre study to define disease activity criteria for systemic sclerosis.* II. Identification of disease activity variables and development of preliminary activity indexes , 2001, Annals of the rheumatic diseases.

[25]  A Sulli,et al.  Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. , 2000, The Journal of rheumatology.

[26]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[27]  J. Highton,et al.  Sequential nailfold capillary microscopy in scleroderma and related disorders. , 1988, Annals of the rheumatic diseases.